Sunday 11 October 2026 Export all UHT data to Excel Powerpack

Universal Health Realty Income Trust

UHT Real Estate Reit Healthcare Facilities

Universal Health Realty Income Trust’s revenue for fiscal 2025 (year ended December 2025) was $99.2 million, roughly unchanged from fiscal 2024. In the quarter to June 2026, revenue was flat, EPS grew 30.3%, free cash flow fell 69.3% and total debt rose 2.73%, each against the same quarter a year earlier. Dividend growth for twenty-five consecutive years, revenue growth for ten.

37.57 0.03 +0.08%
Market cap
$521.8M
P/E
27.0×
Fwd P/E
31.2×
Dividend yield
7.96%
F-score
4/9
Altman Z
n/a
Beneish M
n/a
Dividend safety
n/a
Dec '16 Dec '17 Dec '18 Dec '19 Dec '20 Dec '21 Dec '22 Dec '23 Dec '24 Dec '25
Piotroski F-Score
3 7 5 5 5 5 4 5 7 4
P/E ratio
51.25 22.02 34.87 84.43 45.58 7.49 31.42 39.56 26.77 30.63
P/S ratio
13.17 13.89 11.05 20.89 11.32 9.72 7.30 6.33 5.19 5.46
P/FCF ratio
29.91 32.75 24.29 53.13 43.71 40.07 27.22 22.13 13.57 13.46
P/Operating CF
80.43 81.20 86.93 147.57 77.24 70.95 53.87 57.90 39.05 39.86
P/B ratio
4.62 4.77 4.24 8.87 5.55 3.48 2.89 3.01 2.86 3.56
Price to Tangible BV
5.27 5.29 4.65 9.64 6.00 3.63 3.01 3.16 2.98 3.69
EV/Sales
17.81 17.39 14.41 24.35 15.03 13.36 11.00 10.01 8.83 9.17
EV/EBITDA
26.62 25.68 21.10 36.13 22.50 19.76 17.27 16.04 13.50 14.17
EV/Operating CF
29.34 27.35 25.59 44.06 26.52 23.56 21.31 22.28 18.65 18.53
EV/FCF
40.47 40.99 31.69 61.95 58.03 55.07 41.00 34.97 23.12 22.60
Quick Ratio
0.93 0.98 1.25 1.26 0.82 8.39 7.93 6.54 8.07 6.05
Current Ratio
0.93 0.98 1.25 1.26 0.82 8.39 7.93 6.54 8.07 6.05
Net Debt/EBITDA
6.94 5.16 4.92 5.15 5.55 5.38 5.81 5.89 5.57 5.73
Debt/Assets
60.17% 52.33% 54.01% 55.99% 59.73% 54.94% 56.43% 60.28% 63.40% 66.32%
Debt/Equity
1.65 1.22 1.32 1.51 1.86 1.40 1.50 1.79 2.05 2.46
Asset Turnover
0.14 0.14 0.16 0.16 0.16 0.15 0.15 0.16 0.17 0.17
Operating CF/Net income
2.37 1.01 1.77 2.25 2.27 0.44 2.22 2.79 2.44 2.79
Capex/Depreciation
(0.49) (0.61) (0.33) (0.47) (0.92) (0.97) (0.83) (0.55) (0.32) (0.30)
Interest Coverage
2.36 2.39 2.68 2.44 3.15 3.28 2.85 1.85 1.95 1.84
ROE
8.91% 22.71% 11.83% 9.97% 11.41% 55.37% 9.09% 7.16% 10.11% 10.61%
ROA
3.50% 8.99% 4.97% 3.90% 3.96% 19.99% 3.50% 2.56% 3.27% 3.07%
ROIC
2.75% 3.24% 3.67% 3.58% 3.62% 3.33% 3.40% 3.55% 4.25% 4.18%
Return on Tangible Assets
3.86% 10.22% 5.49% 4.35% 4.42% 20.57% 3.90% 2.95% 3.81% 3.64%
Average Days of Receivables
41.42 45.92 48.89 50.15 50.08 357.41 392.43 318.04 305.23 302.29
Research and Development Expense of Revenue
0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00%
Selling, General and Administrative Expense of Revenue
0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00%
Intangible Assets out of Total Assets
0.05 0.04 0.04 0.03 0.02 0.02 0.02 0.02 0.01 0.01
Share Based Compensation of Revenue
0.72% 0.74% 0.75% 0.91% 1.17% 1.12% 0.86% 0.82% 0.86% 0.94%
Graham Net Nets
(0.36) (0.27) (0.32) (0.18) (0.36) (0.32) (0.41) (0.50) (0.61) (0.60)
Graham Number
20.23 34.13 23.94 20.34 19.16 55.28 23.93 19.08 20.17 17.82
Earnings Yield
1.95% 4.54% 2.87% 1.18% 2.19% 13.35% 3.18% 2.53% 3.74% 3.26%
Free Cash Flow Yield
3.34% 3.05% 4.12% 1.88% 2.29% 2.50% 3.67% 4.52% 7.37% 7.43%
Revenue per Share
4.98 5.31 5.55 5.62 5.68 6.12 6.58 6.93 7.17 7.18
Operating CF per Share
3.03 3.38 3.13 3.11 3.22 3.47 3.40 3.11 3.40 3.55
Capex per Share
(0.83) (1.12) (0.60) (0.90) (1.75) (1.99) (1.63) (1.13) (0.66) (0.64)
Free Cash Flow per Share
2.19 2.25 2.53 2.21 1.47 1.48 1.77 1.98 2.74 2.91
Cash per Share
0.29 0.25 0.37 0.44 0.42 1.64 0.55 0.60 0.51 0.48
Shareholders Equity per Share
14.21 15.45 14.47 13.23 11.57 17.11 16.64 14.58 13.01 11.03
Interest Debt per Share
0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
Book value per Share
14.21 15.45 14.47 13.23 11.57 17.11 16.64 14.58 13.01 11.03
Free Cash Flow
29.53 30.69 34.67 30.33 20.21 20.42 24.32 27.36 37.84 40.26
Working Capital
(0.89) (0.24) 3.03 3.45 (3.71) 92.44 91.80 77.50 78.76 74.14
Capital Expenditures
(11.20) (15.31) (8.26) (12.32) (24.00) (27.31) (22.48) (15.58) (9.07) (8.84)
Net Current Asset Value
(321.93) (266.96) (269.90) (290.34) (318.56) (258.15) (273.39) (303.94) (311.43) (323.69)
EV/EBIT
54.04 52.34 41.13 72.98 45.09 38.95 32.52 30.51 23.77 26.17
Capex to Sales
0.17 0.21 0.11 0.16 0.31 0.32 0.25 0.16 0.09 0.09
Price to Operating Income
39.94 41.82 31.53 62.59 33.97 28.34 21.59 19.31 13.96 15.59
Other line items
Depreciation/Fixed assets
0.05 0.06 0.06 0.06 0.06 0.06 0.06 0.06 0.07 0.07
Cash ROIC
5.78% 6.53% 7.46% 6.57% 4.39% 3.48% 4.20% 4.81% 6.82% 7.54%
Accounts Receivable Turnover
9.57 8.66 7.89 7.42 7.32 1.81 1.01 1.06 1.19 1.20
Accounts Payable Turnover
0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
Inventory Turnover
0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
Average Days of Payables
0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
Days of Inventory on Hand
0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
Average Receivables
7.01 8.36 9.66 10.41 10.65 46.57 89.94 90.36 83.04 82.47
Average Assets
491.63 507.38 486.88 486.27 491.40 546.21 602.98 601.95 588.62 572.88
Average Common Equity
193.16 200.92 204.59 190.17 170.37 197.17 232.21 215.02 190.24 165.96

Fold the line items

Columns are period end dates